HIV/STD Funding Opportunity Announcements
The Centers for Disease Control and Prevention (CDC) recently released the Funding Opportunity Announcement (FOA) PS17-1704: Comprehensive High-Impact HIV Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color which provides fiscal year 2017 funds through a cooperative agreement program to community-based organizations (CBOs) to develop and implement High-Impact HIV Prevention Programs in the following two categories:
Category A: HIV prevention services for Young Men of Color Who Have Sex with Men (YMSM of color) and their partners regardless of age, gender, and race/ethnicity.
Category B: HIV prevention services for Young Transgender Persons of Color (YTG of color) and their partners regardless of age, gender, and race/ethnicity.
Applicants may apply for funding under one category.
Applicants are required to provide HIV prevention services for both HIV-positive persons and HIV-negative YMSM of color and YTG persons of color at high risk of acquiring HIV, regardless of the category for which funding is being requested.
Applicant organizations are required to provide comprehensive HIV prevention services for HIV-positive and HIV-negative YMSM of color and YTG persons of color. The applicant organization’s High-Impact HIV Prevention Program model for HIV-positive and HIV-negative YMSM of color and YTG persons of color at high risk of acquiring HIV must consist of the following program components:
Formalized Collaborations and Partnerships
Program Promotion, Outreach, and Recruitment
Targeted HIV Testing
Comprehensive HIV Prevention with HIV-Positive Persons-Navigation to Continuum of HIV Prevention and Care Services
Comprehensive HIV Prevention with High-Risk HIV-Negative Persons- Navigation to Continuum of HIV Prevention and Care Services
This opportunity is limited to non-profit organizations (e.g., community, faith-based, and tribal organizations) and must be currently located and provide services in one of the 33 states listed below in addition to, District of Columbia, and Puerto Rico. Applicants may provide services in a maximum of three (3) service areas throughout the eligible locations. Applicants can provide HIV prevention services in areas that cross over into eligible bordering state health department jurisdictions (e.g., District of Columbia, Maryland, and Virginia). The applicant must have a history of providing HIV prevention services in these eligible areas, discussed provision of services with their state or local health department in which they report, and received written consent.
Pre-Application Technical Assistance Workshops for FOA PS17-1704: Comprehensive High-Impact HIV Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color were held at the end of July and the first week of August at various locations across the US.
BCHD will offer a PS17-1704 Informational Session on Thursday, August 11, 2016 at its administrative offices, 1001 East Fayette Street, in the Fiscal Conference Room, from 10:30 a.m. to 12:30 p.m. To register for the Informational Session, please visit: https://www.surveymonkey.com/r/79VM7XJ by close of business on Tuesday, August 9, 2016. Questions about BCHD’s August 11th PS17-1704 Informational Session can be sent to: [email protected]
Coordination and collaboration with state or local health departments and HIV Planning Groups is a required component of this grant, and as such, the Baltimore City Health Department (BCHD) is pleased to work with partners interested in responding to the FOA. In order for BCHD to effectively respond to requests for Letters of Support and Letters of Agreement, the following actions are required:
- Forward a copy of your submitted PS17-1704 FOA Letter of Intent (if applicable) to Genevieve Barrow at [email protected] by close of business on Friday, August 5, 2016.
- Submit a summary of the proposed project, indicating the grant category and collaborative partners.
- Allow ten (10) business days for processing requests for data and/or collaboration letters.
For additional information on this FOA, please visit the PS17-1704 website: http://www.cdc.gov/hiv/funding/announcements/ps17-1704/index.html. The website will be updated regularly with new information. Please forward all questions to [email protected].